Skinvisible, Inc.
SKVI
$0.25
-$0.05-16.67%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.00K | 5.00K | 5.00K | 5.00K | 5.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.00K | 5.00K | 5.00K | 5.00K | 5.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 5.00K | 5.00K | 5.00K | 5.00K | 5.00K |
| SG&A Expenses | 114.10K | 105.90K | 136.20K | 139.90K | 198.70K |
| Depreciation & Amortization | 5.10K | 5.10K | 5.10K | 4.90K | 5.10K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 119.20K | 111.10K | 141.20K | 144.90K | 203.70K |
| Operating Income | -114.20K | -106.10K | -136.20K | -139.90K | -198.70K |
| Income Before Tax | -258.40K | -250.20K | -274.40K | -281.00K | 314.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -258.40K | -250.20K | -274.40K | -281.00K | 314.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -258.40K | -250.20K | -274.40K | -281.00K | 314.80K |
| EBIT | -114.20K | -106.10K | -136.20K | -139.90K | -198.70K |
| EBITDA | -109.10K | -100.90K | -131.20K | -134.90K | -193.70K |
| EPS Basic | -0.05 | -0.05 | -0.05 | -0.05 | 0.05 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.03 | -0.03 | 0.03 |
| EPS Diluted | -0.05 | -0.05 | -0.05 | -0.05 | 0.05 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.03 | -0.03 | 0.03 |
| Average Basic Shares Outstanding | 5.40M | 5.40M | 5.40M | 5.36M | 6.63M |
| Average Diluted Shares Outstanding | 5.40M | 5.40M | 5.40M | 5.36M | 6.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |